---
title: "Bank of Marin director Nicolas C Anderson reports $5,053.7 common share purchase"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294539720.md"
description: "Bank of Marin Bancorp director Nicolas C. Anderson purchased 175 common shares at $28.88 each, totaling $5,053.70. This transaction increased his direct stake in the company to 13,786 shares. The information was published via EDGAR on July 31, 2026."
datetime: "2026-07-31T16:48:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294539720.md)
  - [en](https://longbridge.com/en/news/294539720.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294539720.md)
---

# Bank of Marin director Nicolas C Anderson reports $5,053.7 common share purchase

-   Bank of Marin Bancorp director Nicolas C. Anderson bought 175 common shares at USD 28.88 each. \* Anderson’s direct stake rose to 13,786 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bank of Marin Bancorp published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001736209-26-000009), on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BMRC.US](https://longbridge.com/en/quote/BMRC.US.md)

## Related News & Research

- [Bank of Marin Q2 FY26 net income rises 8.6% to $9.25 million; diluted EPS climbs 9.4% to $0.58](https://longbridge.com/en/news/293933158.md)
- [BMRC: Q2 2026 net income and EPS surged on margin expansion, asset quality gains, and cost control](https://longbridge.com/en/news/293934040.md)
- [Kidoz Chief Strategy Officer Ben Tora Eldad reports purchase of common shares worth US$ 505](https://longbridge.com/en/news/294422297.md)
- [Volaris director Ricardo Maldonado Yanez files initial beneficial ownership statement](https://longbridge.com/en/news/294435358.md)
- [CytomX Therapeutics director Charles S. Fuchs files initial beneficial ownership statement](https://longbridge.com/en/news/294418612.md)